Department of Surgery, St Joseph Mercy Hospital, Ann Arbor, Michigan.
Biostatistics and Epidemiology Methods Consulting, BEMC, LLC, Ann Arbor, Michigan.
Dis Colon Rectum. 2020 Oct;63(10):1466-1473. doi: 10.1097/DCR.0000000000001787.
There are currently no guidelines on the management of right colon diverticulitis. Treatment options have been extrapolated from the management of left-sided diverticulitis. Gaining knowledge of the risk and morbidity of diverticulitis recurrence is integral to weighing the benefit of elective surgery for right-sided diverticulitis.
The purpose of this study was to summarize the recurrence rate and the morbidity of recurrence of Hinchey classification I/II, right-sided diverticulitis following nonoperative management.
PubMed, EMBASE, and Cochrane Database of Collected Reviews were searched up to June 2019.
Observational cohort studies evaluating outcomes following nonoperative management were reviewed. No randomized controlled trials were available.
Intravenous antibiotics with or without percutaneous drainage of associated abscess were administered.
The primary outcomes measured were the recurrence rate and morbidity associated with recurrence. Two independent investigators extracted data. The rates of recurrence were pooled by using a random-effects model.
There were 1584 adult participants from a total of 11 studies (9 retrospective cohort and 2 prospective cohort studies) included in the analysis. Over a median follow-up period of 34.2 months, the pooled recurrence rate was 12% (95% CI, 10%-15%). Twenty of 202 patients (9.9%) required urgent surgery at the time of first recurrence. There was no mortality. Subset analysis excluding 3 studies that included percutaneous drainage as a nonoperative treatment option did not change the recurrence rate (12% (95% CI, 9%-15%)) or heterogeneity. Funnel plot assessment revealed no publication bias.
There were no randomized controlled trials available. The statistical heterogeneity was moderate (I = 46%).
Nonoperative management of Hinchey I/II right-sided diverticulitis is safe and feasible. The recurrence rate is relatively low, and complications that require urgent operation are uncommon.
CRD42019131673.
目前尚无关于右结肠憩室炎管理的指南。治疗选择是从左侧憩室炎的治疗中推断出来的。了解憩室炎复发的风险和发病率对于权衡择期手术治疗右侧憩室炎的益处至关重要。
本研究旨在总结非手术治疗后 Hinchey 分类 I/II、右侧憩室炎的复发率和复发的发病率。
截至 2019 年 6 月,检索了 PubMed、EMBASE 和 Cochrane 数据库的综述集。
综述了评估非手术治疗后结局的观察性队列研究。没有随机对照试验。
静脉使用抗生素,伴或不伴相关脓肿的经皮引流。
主要测量的结果是与复发相关的复发率和发病率。两名独立的调查员提取数据。使用随机效应模型对复发率进行汇总。
共有 11 项研究(9 项回顾性队列研究和 2 项前瞻性队列研究)的 1584 名成年参与者纳入分析。在中位随访 34.2 个月期间,汇总的复发率为 12%(95%CI,10%-15%)。202 名患者中有 20 名(9.9%)在首次复发时需要紧急手术。无死亡病例。排除 3 项将经皮引流作为非手术治疗选择的研究的亚组分析并未改变复发率(12%(95%CI,9%-15%))或异质性。漏斗图评估显示无发表偏倚。
没有随机对照试验可用。统计学异质性中等(I = 46%)。
非手术治疗 Hinchey I/II 右侧憩室炎是安全可行的。复发率相对较低,需要紧急手术的并发症并不常见。
CRD42019131673。